Human epididymal protein-4 (HE-4) has been identified as a new tumor marker for ovarian cancer (27), and research has verified that HE-4 is more valuable than CA125 for ovarian cancer (28). This evidence concerns the gene WFDC2 and ovarian carcinoma.